0001179110-12-017255.txt : 20121210 0001179110-12-017255.hdr.sgml : 20121210 20121210175632 ACCESSION NUMBER: 0001179110-12-017255 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121206 FILED AS OF DATE: 20121210 DATE AS OF CHANGE: 20121210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Buckland Martin CENTRAL INDEX KEY: 0001525784 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27628 FILM NUMBER: 121254442 MAIL ADDRESS: STREET 1: 436 CAMBRIDGE SCIENCE PARK STREET 2: MILTON ROAD CITY: CAMBRIDGE STATE: X0 ZIP: CB40QA ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Astex Pharmaceuticals, Inc CENTRAL INDEX KEY: 0000919722 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911841574 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4140 DUBLIN BLVD STREET 2: SUITE 200 CITY: DUBLIN STATE: CA ZIP: 94568 BUSINESS PHONE: 9255600100 MAIL ADDRESS: STREET 1: 4140 DUBLIN BLVD STREET 2: STE 200 CITY: DUBLIN STATE: CA ZIP: 94568 FORMER COMPANY: FORMER CONFORMED NAME: SUPERGEN INC DATE OF NAME CHANGE: 19960125 4 1 edgar.xml FORM 4 - X0306 4 2012-12-06 0 0000919722 Astex Pharmaceuticals, Inc ASTX 0001525784 Buckland Martin C/O ASTEX PHARMACEUTICALS 436 CAMBRIDGE SCIENCE PARK MILTON ROAD CAMBRIDGE X0 CB4 0QA UNITED KINGDOM 0 1 0 0 Chief Business Officer Employee Stock Option (Right to buy) 2.71 2012-12-06 4 A 0 180000 0 A 2022-12-06 Common Stock 180000 180000 D Grant to reporting person of option to purchase shares of Common Stock under the Issuer's 2003 Stock Plan. The option vests and becomes exercisable as to 1/48th of the shares on January 6, 2013 and at the end of each full month thereafter. /s/ Martin Buckland 2012-12-10